Capricor Therapeutics Inc

NASDAQ:CAPR   3:59:50 PM EDT
3.27
-0.14 (-4.11%)
Earnings Announcements

Capricor Therapeutics Reports Q3 Loss Per Share $0.17

Published: 11/09/2021 22:53 GMT
Capricor Therapeutics Inc (CAPR) - Capricor Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.17.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.